Skip to content
BIO FRONTIER
Home
Artificial intelligence
Biotechnology
Genetics
Medical Technology
MITT
Home
MITT
Biotechnology
MITT
Uncategorized
XENE
Xenon announces positive topline data from phase 3 X-TOLE2 study of azetukalner
Mar 9, 2026
Search for: